Revolution Medicines

Director, Global Value Access & Pricing NSCLC

Revolution Medicines • $201K — $251K *
US-AnywhereRemote in United States
Pharmaceuticals & Biotech
8 - 10 years of experience
Job Overview by Ladders

Qualifications

  • Bachelor's degree required; advanced degree preferred (Ph.D., PharmD, MD, or MSc) in relevant fields.
  • 10+ years of experience in market access and pricing, especially in oncology products.
  • Strong knowledge of global payer systems and HTA processes, notably in Europe, Japan, and the US.
  • Proven expertise in developing global pricing strategies, including value-based pricing and launch sequencing.
  • Experience in pricing regulations and negotiation with affiliates on pricing and reimbursement matters.
  • Ability to support clinical development in meeting payer/HTA evidence requirements.
  • Familiarity with biomarker-testing access and companion-diagnostic reimbursement.

Responsibilities

  • Develop and implement global value, access, and pricing strategies for NSCLC assets.
  • Lead the creation of the global value story and payer evidence requirements in collaboration with HEOR.
  • Analyze NSCLC competitive dynamics, focusing on therapy positioning and reimbursement implications.
  • Manage EU Joint Clinical Assessment readiness activities with regional teams.
  • Cultivate relationships across Clinical, Commercial, Regulatory, and Medical Affairs functions.
  • Support regional pricing and reimbursement readiness, integrating insights into global strategies.
  • Advise on clinical development programs to enhance payer and HTA success.

Benefits

  • Competitive cash compensation and robust equity awards.
  • Strong benefits package including significant learning and development opportunities.
  • Flexible work arrangements with options for remote work.
Full Job Description
The Opportunity:

The Director, Global Value, Access & Pricing - NSCLC develops and drives execution of global value, access, and pricing strategies for assigned NSCLC assets and indications. The role ensures payer, HTA, pricing, and evidence requirements inform clinical development, launch preparation, and lifecycle planning to enable timely, sustainable patient access across priority markets.

The Director serves as a core global GVAP lead on cross-functional teams, translating strategy into evidence, pricing, and launch plans. The role partners closely with HEOR, Clinical Development, Regulatory, Commercial, Finance, Medical Affairs, and Regional Market Access to align global and regional execution.

Key responsibilities:
  • Develop and drive implementation of global value, access, and pricing strategies for assigned NSCLC assets and indications, including launch sequencing, pricing architecture, reference pricing considerations, and net price corridor management across priority markets.
  • Lead development of the global value story and payer evidence requirements for assigned NSCLC assets, partnering with HEOR on evidence plans, evidence-gap assessments, and early-advice preparation.
  • Assess NSCLC competitive dynamics, including line-of-therapy positioning, biomarker-driven access and companion-diagnostic testing considerations, and combination-therapy reimbursement implications.
  • Lead cross-functional EU Joint Clinical Assessment (JCA) readiness activities, aligned with global JCA strategy and in collaboration with regional Market Access and HEOR teams.
  • Build and maintain strong relationships with Clinical, Commercial, Regulatory, HEOR, and Medical Affairs functions.
  • Partner with regional teams on local pricing, reimbursement, and negotiation readiness; synthesize regional insights and risks for global decision-making.
  • Provide market access input into clinical development programs to optimize endpoints, comparators, and evidence packages for payer and HTA success.
  • Provide access and pricing analyses and recommendations to lifecycle planning and business development evaluations.

Required Skills, Experience and Education:
  • Bachelor's degree required; advanced degree Ph.D., PharmD, MD, or MSc in Health Economics, Public Health, Health Policy, or a related field preferred.
  • 10+ years of relevant experience in market access and pricing, including significant global and/or major-market responsibility.
  • Strong experience in pricing & reimbursement of oncology products.
  • Deep understanding of global payer systems and HTA processes across Europe (e.g., NICE and G-BA/AMNOG), Japan, and the United States.
  • Experience designing and implementing global pricing strategy, including value-based pricing, launch sequencing, and reference pricing mitigation.
  • Experience with pricing regulations, early pricing analysis, and partnering with affiliates on pricing and reimbursement negotiations.
  • Demonstrated ability to support clinical development to satisfy payer/HTA evidence needs.
  • Experience engaging HTA and payer organizations in early advice to inform development and trial strategies.

Preferred Skills:
  • Strategic and analytical thinking with strong problem-solving skills.
  • Excellent communication, leadership, and cross-functional collaboration abilities.
  • Proven track record influencing decisions and driving results in a matrix organization.
  • Understanding of biomarker-testing access and companion-diagnostic reimbursement.
  • Fluency in English; additional languages are a plus.

#LI-JW1 #LI-Remote

The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.

Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.

Base Pay Salary Range

$201,000-$251,000 USD

We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.

Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.

If you believe you've been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.

About Revolution Medicines

Revolution Medicines is a clinical-stage precision oncology company focused on developing targeted therapies to inhibit elusive frontier targets within notorious growth and survival pathways, with particular emphasis on RAS and mTOR signaling pathways. The company's proprietary platform enables the discovery and development of small molecules that bind covalently to proteins. Revolution Medicines was founded in 2014 and is headquartered in South San Francisco, California.
Learn more about Revolution Medicines
Size
201 employees
Market Cap
$2.1 billion
Industry
Net Income
-$108.1 million
Revenue
$42.9 million
NASDAQ

Similar Jobs

More Jobs at Revolution Medicines

More Pharmaceuticals & Biotech Jobs

Find similar Director, Global Value Access & Pricing NSCLC jobs: